Carlsmed, Inc. CARL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.22% | -32.85% | -22.17% | -- | -- |
| Total Depreciation and Amortization | 139.18% | 134.48% | 93.79% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 148.78% | 157.11% | 93.36% | -- | -- |
| Change in Net Operating Assets | -30.25% | -90.71% | -19.94% | -- | -- |
| Cash from Operations | -26.56% | -29.08% | -13.79% | -- | -- |
| Capital Expenditure | 17.40% | -199.53% | -256.67% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8,700.80% | -15,908.39% | -- | -- | -- |
| Cash from Investing | -4,243.70% | -6,816.03% | -14,057.22% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 48,439.18% | 54,845.61% | 275,400.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -100.00% | -77.26% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.23% | -1,342.78% | -- | -- | -- |
| Cash from Financing | 291.62% | 180.31% | 71.16% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 373.14% | 477.14% | 39.01% | -- | -- |